{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:25:12Z","timestamp":1766690712395,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.msard.2020.102082","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T20:21:37Z","timestamp":1586809297000},"page":"102082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?"],"prefix":"10.1016","volume":"42","author":[{"given":"Regina Maria","family":"Papais Alvarenga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina Ribeiro de Ara\u00fajo e","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1367-9959","authenticated-orcid":false,"given":"Anna Christiany Brand\u00e3o","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja Em\u00eddio Correa de","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie St\u00e9phanie","family":"Meneguette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-6349","authenticated-orcid":false,"given":"Vanderson Carvalho","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Papais Alvarenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helcio Alvarenga","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-0416","authenticated-orcid":false,"given":"Priscilla de Oliveira","family":"Barros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-6608","authenticated-orcid":false,"given":"Cleonice Alves","family":"Bento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Luis","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-4024","authenticated-orcid":false,"given":"Claudia Cristina Ferreira","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-8619","authenticated-orcid":false,"given":"Marcos Papais","family":"Alvarenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1894","series-title":"De la neuromy\u00e9lite optique aigu\u00eb","author":"Gault","key":"10.1016\/j.msard.2020.102082_bib0001"},{"key":"10.1016\/j.msard.2020.102082_bib0002","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.410340211","article-title":"Devic\u00b4s neuromyelitis optica: a clinicopathological study of 8 patients","volume":"34","author":"Mandler","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2020.102082_bib0003","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.410400405","article-title":"Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders","volume":"40","author":"Kira","year":"1996","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.msard.2020.102082_bib0004","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","article-title":"Clinical,CSF, and MRI findings in Devic\u00b4s neuromyelitis optica","volume":"60","author":"O\u00b4Riordan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.msard.2020.102082_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1212\/WNL.48.1.58","article-title":"Recurrent optic neuromyelitis with endocrinopathies: a new syndrome","volume":"48","author":"Vernant","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0006","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuro- myelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0007","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1474-4422(03)00308-9","article-title":"Multiple sclerosis in the Japanese population","volume":"2","author":"Kira","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2020.102082_bib0009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of opticospinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"4","author":"Lennon","year":"2005","journal-title":"J Exp Med."},{"key":"10.1016\/j.msard.2020.102082_bib0008","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2020.102082_bib0010","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0011","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2020.102082_bib0042","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1352458515586089","article-title":"Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2020.102082_bib0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/WNL.0000000000001224","article-title":"Neurology in Asia","volume":"84","author":"Tan","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0012","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/1352458507076976","article-title":"Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions","volume":"13","author":"Tanaka","year":"2007","journal-title":"Mult. Scler"},{"key":"10.1016\/j.msard.2020.102082_bib0013","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00415-006-0400-z","article-title":"Two subtypes of opticospinal form of multiple sclerosis in Japan: clinical and laboratory features","volume":"254","author":"Nakashima","year":"2007","journal-title":"J Neurol."},{"issue":"6","key":"10.1016\/j.msard.2020.102082_bib0028","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.msard.2020.102082_bib0014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0015","first-page":"184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J Neuro inflammation"},{"key":"10.1016\/j.msard.2020.102082_bib0041","first-page":"737","article-title":"Clinical analysis of opticospinal multiple sclerosis (OSMS) presentation detection anti-myelin oligodendrocyte glycoprotein (MOG) antibody","volume":"58","author":"Kitagawa","year":"2018","journal-title":"Clin Neurol"},{"key":"10.1016\/j.msard.2020.102082_bib0016","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","article-title":"Myelin oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype","volume":"79","author":"Kitley","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-015-0256-1","article-title":"Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitisoptica phenotype","volume":"12","author":"Pr\u00f6bstel","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.msard.2020.102082_bib0019","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.msard.2018.07.026","article-title":"Lower frequency of antibodies to MOG in Brazilian patients with demyelinating diseases: An ethnicity influence?","volume":"25","author":"Papais-Alvarenga","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2020.102082_bib0022","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (Explanation and Elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.msard.2020.102082_bib0023","first-page":"2","article-title":"Miranda-Santos CM - SIAPEM - Brazilian Software Database for Multiple Sclerosis Research in Tropical Countries (English)- African","volume":"22","author":"Papais Alvarenga","year":"2003","journal-title":"Journal of Neurological Sciences"},{"key":"10.1016\/j.msard.2020.102082_bib0018","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J Neurol."},{"key":"10.1016\/j.msard.2020.102082_bib0024","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2020.102082_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127757","article-title":"Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study","volume":"10","author":"Papais-Alvarenga","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.msard.2020.102082_bib0026","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the \u201cMcDonald criteria\u201d","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2020.102082_bib0025","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.msard.2020.102082_bib0027","doi-asserted-by":"crossref","unstructured":"Kurtze J.Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology. 1983;33:1444-1452.","DOI":"10.1212\/WNL.33.11.1444"},{"key":"10.1016\/j.msard.2020.102082_bib0029","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2020.102082_bib0030","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Mult Scler Relat Disord."},{"key":"10.1016\/j.msard.2020.102082_bib0031","unstructured":"Multiple Sclerosis International Federation.Atlas of MS 2013: Mapping multiple sclerosis around the world. (Multiple Sclerosis International Federation, 2013)."},{"key":"10.1016\/j.msard.2020.102082_bib0043","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1172\/JCI28334","article-title":"Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice","volume":"116","author":"Bettelli","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.msard.2020.102082_bib0032","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00415-009-5171-x","article-title":"Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution","volume":"256","author":"Bizzoco","year":"2009","journal-title":"J Neurol."},{"key":"10.1016\/j.msard.2020.102082_bib0033","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/jnnp.2007.131177","article-title":"Characterization of the spectrum of demyelinating disease in Western Australia","volume":"79","author":"Wu","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.msard.2020.102082_bib0034","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102082_bib0036","doi-asserted-by":"crossref","first-page":"939","DOI":"10.5692\/clinicalneurol.54.939","article-title":"My way to \u201cKeep Pioneering\u201d: Integrated neuroscience and immunology research produces a paradigm shift for intractable neurological disease","volume":"54","author":"Kira","year":"2014","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.msard.2020.102082_bib0037","unstructured":"IBGE (1999) - https:\/\/www.ibge.gov.br\/en\/cities-and-states\/rj\/.html."},{"key":"10.1016\/j.msard.2020.102082_bib0039","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1352458513495580","article-title":"The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project","volume":"20","author":"Papais-Alvarenga","year":"2014","journal-title":"Mult Scler."},{"key":"10.1016\/j.msard.2020.102082_bib0038","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.msard.2015.08.004","article-title":"Prevalence of Multiple Sclerosis in Brazil: a systematic review","volume":"4","author":"Da Gama Pereira","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2020.102082_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clineuro.2011.07.020","article-title":"Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis","volume":"114","author":"Etemadifar","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.msard.2020.102082_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.msard.2016.03.011","article-title":"Prognostic factors associated with long-term disability and secondary progression in patients with Multiple Sclerosis","volume":"8","author":"Vasconcelos","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2020.102082_bib0044","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijdevneu.2012.05.004","article-title":"The Brown Norway opticospinal model of demyelination: does it mimic multiple sclerosis or neuromyelitis optica?","volume":"30","author":"Collongues","year":"2012","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.msard.2020.102082_bib0046","series-title":"In Mc Alpine's Multiple Sclerosis. 4a edition","first-page":"183","article-title":"The natural history of Multiple Sclerosis","author":"Confavreux","year":"2006"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820301589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820301589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:48:19Z","timestamp":1761900499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820301589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":46,"alternative-id":["S2211034820301589"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102082","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102082"}}